MKI67 and breast carcinoma: In addition, more unfovourable survival outcomes in breast cancer patients with recurrent lesions were significantly correlated with high Ki-67 immunohistochemical expression levels (hazard ratio 2.307; 95% confidence interval 1.207–4.407, p-value = 0.011) [30].